DOP003: Gene Expression Profiling Indicates Similar Molecular Pathways Are Active in Adult And Pediatric Ulcerative ColitisECCO'16 DOP 2016
1
DOP004: Epigenetic control of colonic epithelial antigen processing, barrier function, and the microbiome via methyl-CpG binding domain protein 2ECCO'16 DOP 2016
1
DOP006: Gut homing adipose tissue T-cells might influence intestinal barrier function in Crohn’s disease and obesityECCO'16 DOP 2016
1
DOP007: Interleukin-10 inhibits human IFN#CHR:gamma_LOWER# and IL-17-producing T helper cells indirectly by controlling antigen-presenting cell functionECCO'16 DOP 2016
1
DOP009: An autoimmunity-associated variant in PTPN22 protects from disease onset in mouse models of colitisECCO'16 DOP 2016
1
DOP011: Early immunomodulator exposure and the long-term outcome of Crohn’s disease: target for changing the natural history?ECCO'16 DOP 2016
1
DOP012: Do ulcerative colitis patients treated withcorticosteroids at diagnosis really have a more aggressive disease course?ECCO'16 DOP 2016
1
DOP013: A 104 week mucosal healing assessment of symptomatic small bowel Crohn’s diseaseECCO'16 DOP 2016
1
DOP014: Nutritional optimisation of pre-surgical Crohn’s disease patients with enteral nutrition significantly decreases length of stay and need for a stomaECCO'16 DOP 2016
1
DOP015: Myenteric plexitis is a risk factor for endoscopic and clinical postoperative recurrence after ileocolonic resection in Crohn’s diseaseECCO'16 DOP 2016
1
DOP017: Colectomy Free Survival is Independent of Initial Infliximab Dosing Strategy in Hospitalised Ulcerative Colitis PatientsECCO'16 DOP 2016
1